Contradictory regulation of SPARC has been documented in the initiation and progression of cancer, although the majority of existing literature reveals that downregulation of SPARC is closely associated with the aggressive phenotype of breast cancer progression (69, 70). The gene discussed is SPARC; the disease is breast cancer.